Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 18 | $1.30 | $1.35 | $1.34 |
| Q2 2026 | 19 | $1.62 | $1.69 | $1.67 |
| Q3 2026 | 15 | $1.30 | $1.43 | $1.38 |
| Q4 2026 | 12 | $1.40 | $1.50 | $1.44 |
| Q1 2027 | 7 | $1.43 | $1.52 | $1.47 |
| Q2 2027 | 7 | $1.74 | $1.85 | $1.78 |
| Q3 2027 | 7 | $1.41 | $1.51 | $1.45 |
| Q4 2027 | 7 | $1.50 | $1.60 | $1.54 |
| Q1 2028 | 7 | $1.53 | $1.63 | $1.57 |
| Q2 2028 | 7 | $1.89 | $2.01 | $1.94 |
Medtronic Plc last posted its earnings results on Tuesday, February 17th, 2026. The company reported $1.36 earnings per share for the quarter, topping analysts' consensus estimates of $1.34 by $0.02. The company had revenue of 9.02 B for the quarter and had revenue of 33.54 B for the year. Medtronic Plc has generated $4 earnings per share over the last year ($3.61 diluted earnings per share) and currently has a price-to-earnings ratio of 26.91. Medtronic Plc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 02/17/2026 | Q3 2026 | $1.34 | $0.89 | -0.45 | $8.91 B | $9.02 B |
| 11/25/2025 | Q2 2026 | N/A | $1.07 | N/A | N/A | $8.96 B |
| 08/26/2025 | Q1 2026 | N/A | $0.81 | N/A | N/A | $8.58 B |
| 06/20/2025 | Q4 2025 | N/A | $0.82 | N/A | N/A | $8.93 B |
| 02/25/2025 | Q3 2025 | N/A | $1.01 | N/A | N/A | $8.29 B |
| 11/26/2024 | Q2 2025 | N/A | $0.99 | N/A | N/A | $8.40 B |
| 08/27/2024 | Q1 2025 | N/A | $0.81 | N/A | N/A | $7.92 B |
| 06/20/2024 | Q4 2024 | N/A | $0.49 | N/A | N/A | $8.59 B |
| 02/27/2024 | Q3 2024 | N/A | $0.99 | N/A | N/A | $8.09 B |
| 11/30/2023 | Q2 2024 | N/A | $0.68 | N/A | N/A | $7.98 B |
| 08/31/2023 | Q1 2024 | N/A | $0.59 | N/A | N/A | $7.70 B |
| 06/22/2023 | Q4 2023 | N/A | $0.89 | N/A | N/A | $8.54 B |
| 03/01/2023 | Q3 2023 | N/A | $0.92 | N/A | N/A | $7.73 B |
| 12/01/2022 | Q2 2023 | N/A | $0.32 | N/A | N/A | $7.59 B |
| 09/01/2022 | Q1 2023 | N/A | $0.70 | N/A | N/A | $7.37 B |
| 06/23/2022 | Q4 2022 | N/A | $1.11 | N/A | N/A | $8.09 B |
| 03/03/2022 | Q3 2022 | N/A | $1.10 | N/A | N/A | $7.76 B |
| 12/02/2021 | Q2 2022 | N/A | $0.97 | N/A | N/A | $7.85 B |
| 09/02/2021 | Q1 2022 | N/A | $0.57 | N/A | N/A | $7.99 B |
| 06/25/2021 | Q4 2021 | N/A | $1.01 | N/A | N/A | $8.19 B |
In the previous quarter, Medtronic Plc (:MDT) reported $1.36 earnings per share (EPS) to beat the analysts' consensus estimate of $1.34 by $0.02.
The conference call for Medtronic Plc's latest earnings report can be listened to online.
The conference call transcript for Medtronic Plc's latest earnings report can be read online.
Medtronic Plc (:MDT) has a recorded annual revenue of $33.54 B.
Medtronic Plc (:MDT) has a recorded net income of $4.66 B.Medtronic Plc has generated $3.63 earnings per share over the last four quarters.
Medtronic Plc (:MDT) has a price-to-earnings ratio of 26.91 and price/earnings-to-growth ratio is -8.32.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED